Cryo Cell International Inc
CCEL- Exchange
- NYSE
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0000862692
No open-market purchases or sales by Cryo Cell International Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $1.77M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Cryo Cell International Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 14 | 20 | +6 |
| Shares | 901.3K | 1.03M | +130.0K (+14.4%) |
| Value | $5.74M | $7.64M | +$1.90M (+33.1%) |
New holders (6)
Institutions that held Cryo Cell International Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Topline Capital Management, LLC | 47,791 | $354.1K | 0.07% |
| Heron Bay Capital Management | 31,766 | $235.4K | 0.05% |
| Change Path, LLC | 15,310 | $113.4K | 0.00% |
| Rowland & Co Investment Counsel | 14,433 | $106.9K | 0.02% |
| SBI Securities Co., Ltd. | 105 | $778 | 0.00% |
| Northwestern Mutual Wealth Management Co | 100 | $741 | 0.00% |
Sold out (0)
Institutions that held Cryo Cell International Inc at the end of Q3 2024 and filed for Q4 2024 without it.
None.